European Society of Toxicology In Vitro > News > Guidance and standards for increasing regulatory confidence in in vitro and PBK models
27 June 2022

Guidance and standards for increasing regulatory confidence in in vitro and PBK models

Thursday, July 28, 2022
1:00-2:00pm EDT

Registration is open!

Guidance for increasing confidence in Physiologically Based Kinetic models … are we ready for a regulatory change? 

Alicia Paini, PhD, ERT,  esqLABS GmbH 

Physiologically based kinetic (PBK) models are routinely applied in several sectors, including academia and industry, as a means of integrating data on absorption, distribution, metabolism, and excretion (ADME) in humans and animals to predict whole-body biokinetic behavior. Use of these models has increased, especially in conjunction with emerging alternative methods to animal testing, now called new approach methodologies (NAMs). Experimental information derived from NAMs can be used as input for model parameterization and allows for increased confidence in models for chemicals that are lacking in vivo data for model calibration and evaluation. Despite significant advancements in good modelling practice (GMP) for model development and evaluation, there remains some reluctance among regulatory agencies to use such models during the risk assessment process. To fill this gap the Organisation for Economic Cooperation and Development (OECD) published a guidance document (GD) describing a scientific workflow for characterising and validating PBK models developed using NAMs data and with a lack of in vivo data for model evaluation. The GD provides an assessment framework for evaluating these models, with emphasis on the major uncertainties underlying model inputs and outputs. To help end-users develop and  evaluate a PBK model for regulatory purposes, the document includes a template for documenting the model characteristics, and a checklist for evaluating the quality of a model. It was designed to facilitate the dialogue between model developers and risk assessors. The following presentation will highlight the principles, criteria and tools laid out in the OECD PBK model GD, with insight into the journey that lead to this document.   

Implementing Good In Vitro Method Practices (GIVIMP) as a Quality Standard in a Laboratory

Amanda Ulrey, Institute for In Vitro Sciences, Inc. (IIVS)

Over the past several years science has put renewed energy into improving the reproducibility of data. There are many articles, strategies, and tools to help with this that are specific to the field of in vitro toxicology, such as systematic reviews of published work (and tools to help educate on how to perform them), publishing Good Cell Culture Practices (and GCCP 2.0), improvements made to the method validation process itself, and increased acceptance and use of in vitro methods within the Good Laboratory Practices (GLP) quality system. Another tool for improving the reproducibility of in vitro work is the implementation of the practices described in the OECD’s guidance document Good In Vitro Method Practices, or GIVIMP. The GIVIMP guideline is applicable to academic laboratories developing new alternative methodologies, established laboratories participating in validations and performing routine in vitro studies, and industry laboratories intending to submit in vitro data to regulatory agencies. These diverse types of institutions have different capabilities for developing and instituting quality systems that adhere to published recommendations while also suiting the unique operational environment of their facilities. This webinar will provide examples of and share a practical strategy for using the GIVIMP document to assess current laboratory processes and increase the reliability and robustness of work performed within a facility. GIVIMP has been used to prioritize areas of focus for building new and expanding existing good quality practices within the laboratory.

Related content

Be aware of scammers…..

Please be aware, that ESTIV and many other EU-based societies are currently facing the incased activity of scams and fraudulent e-mails requesting bank transfers to various accounts. ….

ESTIV Applied Training Course shortlisted for LUSH Prize

ESTIV is proud to announce that its training programme in NAMs (New approach Methodologies), the ESTIV Applied Training course, has been shortlisted for the 2022 LUSH prize.

NURA Sessions – DyNAMic Discussions: The Future is Already Here

Please join the Physicians Committee for Responsible Medicine’s New Approach Methodologies (NAMs) Use for Regulatory Applications (NURA) Friday, June 24 at 10:00-11:30 am EDT …

Gold Sponsor

Silver Sponsor

Corporate Members

Affiliated Societies

Memorandum of Understanding